approved EB-1A
Senior Research Specialist
Biomedical Science · China · 2025-10-23
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 18 peer-reviewed journal articles, including 6 as first author, in the field of biomedical science.
Judging (Met)
The petitioner completed at least 19 professional peer-review assignments for respected journals in their field.
Original Contributions (Met)
The petitioner's research on isoflurane and neurological development is recognized for advancing pediatric clinical practices and is supported by 280 citations.
Why This Petition Was Approved
The petition was approved based on 18 peer-reviewed journal articles (6 first-authored) and 280 citations demonstrating widespread reliance on the findings. The petitioner also provided evidence of 19 professional peer-review assignments for respected journals. Additionally, the work received funding support connected to the National Institutes of Health (NIH), signifying its recognized importance.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Evidence Submitted
- 18 peer-reviewed journal articles (6 first-authored)
- 280 citations from researchers worldwide
- 19 professional peer-review assignments
- NIH-connected funding support
- Four authoritative recommendation letters
Similar Cases
Research Scientist
Research and Development · India
WeGreened EB-1A rfe approved
Texas 569 days 2025-12-15
The petition satisfied the EB-1A criteria through 18 peer-reviewed journal articles and a book chapter. The petitioner demonstrated significant influence with 432 citations and a trusted role in the field with 39 completed peer reviews. Major governmental research funding further validated the importance of his contributions to neurodegenerative disease research.
Postdoctoral Researcher
Healthcare · Japan
WeGreened EB-1A approved
Ohio 17 days 2025-10-02
The petition was approved based on 28 peer-reviewed journal articles, 9 abstracts, and 1 book chapter, with several papers ranked in the top 1% of most-cited papers in clinical medicine. The petitioner demonstrated 262 citations from scholars in 37 countries and completed 27 peer reviews for major journals. Her research was also shown to have informed international guidelines from the European Cardiac Arrhythmias Society.
Postdoctoral Researcher
Healthcare · Iraq
WeGreened EB-1A rfe approved
86 days 2025-10-13
The approval was based on an exceptional record of 152 peer-reviewed journal articles and 493 citations, demonstrating scholarly leadership. Additionally, the petitioner completed at least 70 scientific judging assignments for leading journals. The research was found to address critical societal needs in behavioral diagnostics and neurovascular surgery.
Research Scientist
Research and Development · China
WeGreened EB-1A approved
New York 14 days 2025-08-14
The petition was approved based on 10 peer-reviewed journal articles, 409 citations, and the completion of at least 38 peer reviews. The evidence satisfied the EB-1A criteria for original contributions, scholarly articles, and judging the work of others.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-23.
Browse all casesAt a Glance
Outcome approved
Processing 496 days
Criteria Met 3 / 3
Evidence Types 5
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist